Table 1 Patient´s characteristics.
From: Methylene blue administration in patients with refractory distributive shock – a retrospective study
Responders, n = 9 | Non-responders, n = 11 | P-value | |
|---|---|---|---|
Age (years) | 57.9 ± 19.3 | 70.3 ± 8.1 | 0.068 |
Gender - males | 5 (55.6%) | 6 (54.5%) | 0.091 |
BMI (kg/m2) | 26.5 ± 5 | 26.3 ± 3.2 | 0.947 |
Hypertension | 2 (22.2%) | 8 (72.7%) | 0.070 |
Diabetes mellitus | 0 | 3 (27.3%) | 0.218 |
COPD | 2 (22.2%) | 3 (27.3%) | 1.000 |
Renal insufficiency | 2 (22.2%) | 4 (36.4%) | 0.642 |
Peripheral vascular disease | 2 (22.2%) | 2 (18.2%) | 1.000 |
CAD | 1 (11.1%) | 5 (45.5%) | 0.157 |
LV EF (%) | 54.3 ± 14.2 | 58.1 ± 11.8 | 0.526 |
NYHA I. | 3 (33.3%) | 0 | 0.074 |
II. | 0 | 1 (9.1%) | |
III. | 6 (66.6%) | 7 (63.6%) | |
IV. | 0 | 3 (27.3%) |
